Working on stories relating to World TB Day on March 24? We suggest the following McGill University and McGill University Health Centre experts:
Dr. Marcel Behr
Researcher in the Infection and Immunity Axis at the RI MUHC, Associate Professor of Medicine and William Dawson Scholar at McGill.
Expertise: Dr. Behr’s research focuses on the epidemiology and pathogenesis of mycobacterial infections, specifically Mycobacterium tuberculosis - the bacterial agent responsible for TB - using DNA fingerprinting and whole genome sequencing.
Dr. Maziar Divangahi
Assistant Professor in the Departments of Medicine, Microbiology & Immunology at McGill and a researcher in the Infection and Immunity Axis at the RI MUHC
Expertise: Dr. Divangahi’s research focuses on immunity against two intracellular pulmonary pathogens - influenza and Mycobacterium tuberculosis.
Dr. Dick Menzies
MUHC Director of Respiratory Medicine, researcher in the Respiratory Health Axis and Health Outcomes Axis at the RI MUHC and McGill professor in the Departments of Medicine and Epidemiology, Biostatistics & Occupational Health.
Expertise: Dr. Menzies’s research interests include new diagnostics and treatment for latent and active TB, including drug resistant TB. Dr. Menzies also studies the epidemiology of TB in Canada and abroad, including the impact and the cost-effectiveness of strategies for global TB control.
Dr. Madhukar Pai
Assistant professor in McGill’s Department of Epidemiology, Biostatistics & Occupational Health and a researcher in the Respiratory Epidemiology and Clinical Research Unit at the Montreal Chest Institute and the RI MUHC.
Expertise: Dr. Pai’s investigates advanced global tuberculosis care and control through the epidemiology of TB and evaluation of new diagnostics and tools in diverse populations and settings.
Dr. Erwin Schurr
Researcher at the Centre for the Study of Host Resistance at the RI MUHC and molecular geneticist in the Department of Human Genetics at McGill.
Expertise: Dr. Schurr’s research focuses on the genetic factors that predispose people to TB. He is working on the identification of host gene variants that determine the protective efficacy of present and newly developed TB vaccines.
Dr. Kevin Schwartzman
Clinician-researcher at the Respiratory Epidemiology and Clinical Research Unit at the Montreal Chest Institute of the MUHC, and Associate Professor of Medicine, McGill
Expertise: Dr. Schwartzman’s research focuses on the epidemiology of TB, with emphasis on molecular and geographic applications in Montreal. He also investigates the cost-effectiveness of TB control interventions, including immigrant screening and TB vaccines.